Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Stay Logged In

Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Recombinant Proteins  >  HCV (Hepatitis C Virus)  >>  HCV NS3/4A protease mutant V170A, recombinant

Product Name HCV NS3/4A protease mutant V170A, recombinant
Size 5 g
Catalog # AS-72035-5
US$ $259

The Hepatitis C Virus (HCV) NS3/4A serine protease is essential for viral replication and the formation of infectious viral particles, and thus has been considered as one of the most attractive targets for anti-HCV therapy. Due to poor fidelity of viral reverse transcriptase and RNA-dependent RNA polymerase, drug resistant mutations emerge rapidly against protease inhibitors. Three mutations, V170A, T54A, and A156S, were identified to confer low to moderate levels of resistance (<20-fold) to HCV NS3/4A protease inhibitor SCH503034.

The recombinant HCV NS3/4A protease mutant V170A is derived from its wild type (NCBI Accession: CAB46913) with a substitution of Val170 with Ala. It is a 217 amino acid fusion protein with NS3 protease domain and a fragment of the NS4A protein fused to its N-terminus.

Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Storage -80C
  < Back